Professor Graeme Hankey is a world-renowned neurologist whose career has fundamentally shaped contemporary approaches to stroke management and prevention. He currently holds the distinguished position of Perron Institute Chair in Stroke Research at The University of Western Australia and the Perron Institute for Neurological and Translational Science. A graduate of the University of Western Australia medical school, he completed his specialized neurology training at Royal Perth Hospital, Mayo Clinic in the United States, and Western General Hospital in Edinburgh, United Kingdom. Since 1992, he has maintained a full-time hospital appointment as a Consultant Neurologist, expertly integrating clinical practice with rigorous research to advance patient care. His dual appointments at Sir Charles Gairdner Hospital and Royal Perth Hospital have positioned him at the forefront of neurological medicine in Australia.
Professor Hankey's research program has established new paradigms in stroke epidemiology and treatment through meticulously designed clinical trials that have directly influenced international stroke guidelines. His scholarly contributions exceed 1,118 publications including 13 authoritative books, 758 original research articles, and 117 comprehensive review papers, accumulating over 37,000 citations with an impressive H-index of 80. He and his research collaborators have secured more than $80 million in competitive research funding, including substantial grants from the National Health and Medical Research Council. His epidemiological studies have provided critical insights into stroke risk factors and outcomes across diverse populations, while his clinical trials have validated effective interventions for acute stroke treatment and secondary prevention. This exceptional research output has cemented his reputation as one of the most influential stroke researchers of his generation.
Beyond his research achievements, Professor Hankey serves in significant editorial capacities as Associate Editor of Stroke and as an editorial consultant for The Lancet, helping to shape the global discourse on cerebrovascular disease. His exceptional contributions have been recognized with numerous prestigious honors including the Western Australian Premier's prize for achievement in science and the American Stroke Association's David G. Sherman Lecture Award for outstanding lifetime contributions to stroke research. He has delivered more than 500 invited lectures at scientific conferences worldwide and has mentored countless neurologists who now lead stroke programs across the globe. As a member of multiple professional associations and editorial boards, he continues to influence stroke research methodology and clinical practice standards internationally. Professor Hankey remains actively engaged in advancing stroke care through innovative research that promises to further reduce the global burden of this devastating condition.
